Icu Medical Inc/de
A maker of infusion therapy and IV safety products headquartered in San Clemente, California, ICU Medical produces the Plum family of infusion pumps, needle-free connectors like the MicroClave, and IV sets used by hospitals and clinics around the world. Physician Dr. George "Doc" Lopez founded the company in 1984 after inventing a device to better secure intravenous lines; the name comes from the Intensive Care Unit. Its best-known invention is the Clave needleless connector, which lets staff connect syringes and IV lines without ever touching a needle.
Granted 134.9K
Granted 22.8K · Sold 2.1K
Granted 36.8K · Sold 2.4K
Granted 1.3K
Granted 1.3K
Granted 1.3K
Granted 1.3K
Granted 1.3K
Granted 3.7K · Sold 2.4K
Granted 89.9K
Granted 10.8K
Granted 89.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Jain VivekChairman and CEO, Director · 8 transactions | -11.2% | 371.2K | 134.9K | — | — |
| Woolson DanielPresident · 9 transactions | +99% | 22.5K | 22.8K | — | 2.1K |
| Sanzone Virginia RuthVP, General Counsel · 11 transactions | +256.7% | 19.5K | 36.8K | — | 2.4K |
| Abbey DonaldDirector · 2 transactions | — | 1.5K | 1.3K | — | — |
| Finney Elisha WDirector · 1 transaction | -63.1% | 1.5K | 1.3K | — | — |
| Hernandez LaurieDirector · 1 transaction | +17.6% | 1.5K | 1.3K | — | — |
| Hoffmeister David FDirector · 1 transaction | +17.6% | 1.5K | 1.3K | — | — |
| Kennedy Kolleen TDirector · 1 transaction | — | 1.5K | 1.3K | — | — |
| Greenberg David C.Director · 3 transactions | -94.1% | 500 | 3.7K | — | 2.4K |
| Bonnell Brian MichaelChief Financial Officer · 8 transactions | -100% | 0 | 89.9K | — | — |
| Sousa BenChief Information Officer · 8 transactions | -100% | 0 | 10.8K | — | — |
| Voigtlander Christian B.Chief Operating Officer · 8 transactions | -100% | 0 | 89.9K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -7.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.